BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang W, Tang YA, Xiao Q, Lee WC, Cheng B, Niu Z, Oguz G, Feng M, Lee PL, Li B, Yang ZH, Chen YF, Lan P, Wu XJ, Yu Q. Stromal induction of BRD4 phosphorylation Results in Chromatin Remodeling and BET inhibitor Resistance in Colorectal Cancer. Nat Commun 2021;12:4441. [PMID: 34290255 DOI: 10.1038/s41467-021-24687-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Liu N, Ling R, Tang X, Yu Y, Zhou Y, Chen D. Post-Translational Modifications of BRD4: Therapeutic Targets for Tumor. Front Oncol 2022;12:847701. [DOI: 10.3389/fonc.2022.847701] [Reference Citation Analysis]
2 Sun HY, Du ST, Li YY, Deng GT, Zeng FR. Bromodomain and extra-terminal inhibitors emerge as potential therapeutic avenues for gastrointestinal cancers. World J Gastrointest Oncol 2022; 14(1): 75-89 [DOI: 10.4251/wjgo.v14.i1.75] [Reference Citation Analysis]
3 Zhong B, Cheng B, Huang X, Xiao Q, Niu Z, Chen YF, Yu Q, Wang W, Wu XJ. Colorectal cancer-associated fibroblasts promote metastasis by up-regulating LRG1 through stromal IL-6/STAT3 signaling. Cell Death Dis 2021;13:16. [PMID: 34930899 DOI: 10.1038/s41419-021-04461-6] [Reference Citation Analysis]
4 Zhang Y, Song C, Zhang Y, Wang Y, Feng C, Chen J, Wei L, Pan Q, Shang D, Zhu Y, Zhu J, Fang S, Zhao J, Yang Y, Zhao X, Xu X, Wang Q, Guo J, Li C. TcoFBase: a comprehensive database for decoding the regulatory transcription co-factors in human and mouse. Nucleic Acids Res 2021:gkab950. [PMID: 34718747 DOI: 10.1093/nar/gkab950] [Reference Citation Analysis]
5 Zhang X, Zheng S, Hu C, Li G, Lin H, Xia R, Ye Y, He R, Li Z, Lin Q, Chen R, Zhou Q. Cancer-associated fibroblast-induced lncRNA UPK1A-AS1 confers platinum resistance in pancreatic cancer via efficient double-strand break repair. Oncogene 2022. [PMID: 35264742 DOI: 10.1038/s41388-022-02253-6] [Reference Citation Analysis]